rs1556329779
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_000206.3(IL2RG):c.903_910delTGAATACC(p.Glu302ArgfsTer11) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000206.3 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IL2RG | ENST00000374202.7 | c.903_910delTGAATACC | p.Glu302ArgfsTer11 | frameshift_variant | Exon 7 of 8 | 1 | NM_000206.3 | ENSP00000363318.3 | ||
ENSG00000285171 | ENST00000646505.1 | n.903_910delTGAATACC | non_coding_transcript_exon_variant | Exon 7 of 12 | ENSP00000496673.1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
X-linked severe combined immunodeficiency Pathogenic:2
This sequence change deletes 8 nucleotides from exon 7 of the IL2RG mRNA (c.903_910delTGAATACC), causing a frameshift at codon 302. This creates a premature translational stop signal in the last exon of the IL2RG mRNA (p.Glu302Argfs*11). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 66 amino acids of the IL2RG protein. This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with an IL2RG-related disease. While the effect of this particular variant has not been studied, it is expected to disrupt the C-terminal region of the interleukin receptor common gamma chain, which is known to be critical for proper association with Jak3 (PMID: 7973658, 7973659). Deletions affecting this intracellular region of the protein have been shown to lead to defects in signal transduction, including loss of ability to induce c-myc, c-fos, and c-jun expression (PMID: 7683423). In summary, this is a novel truncation that disrupts a protein domain that is essential for proper IL2 receptor function. Therefore this variant has been classified as Pathogenic. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at